Thermo Fisher (TMO) Tops Q4 EPS by 3c; Issues In-Line FY12 EPS Outlook, Revs Light
Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.18, $0.03 better than the analyst estimate of $1.15. Revenue for the quarter came in at $3.13 billion versus the consensus estimate of $3.08 billion.
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Thermo Fisher Scientific sees FY2012 EPS of $4.67-$4.82, versus the consensus of $4.72. Sees FY2012 revenue of $12.15-$12.35 billion, versus the consensus of $12.56 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.